Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of a 15-valent pneumococcal conjugate vaccine in infants
ChiCTR2000032303Phase 3Not yet recruiting
- Sponsor
- Hebei Provincial Center for Disease Control and Prevention
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of 15-valent pneumococcal conjugate vaccine in pneumococcal disease (3 arms), sponsored by Hebei Provincial Center for Disease Control and Prevention. Primary endpoints: Immunogenicity and Safety. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
15-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on ChiCTR2000032303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032303.